{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:53:14Z","timestamp":1781628794485,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The study was supported by the National Clinical Key Specialty Construction Program, P. R","award":["China (2022)301-2305."],"award-info":[{"award-number":["China (2022)301-2305."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extranodal natural killer (NK)\/T-cell lymphomas constitute less than 1% of non-Hodgkin lymphomas, with central nervous system involvement and chylothorax representing exceptionally rare presentations. This unique combination has not been previously reported in emergency medicine literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A previously healthy 51-year-old Chinese male presented with progressive dyspnea, high fever, and bilateral pleural effusion over eight days. Physical examination revealed extensive ecchymoses, bilateral lung consolidation, and splenomegaly. Laboratory studies demonstrated pancytopenia (WBC 3.26\u2009\u00d7\u200910\u2079\/L, platelets 58\u2009\u00d7\u200910\u2079\/L), severe coagulopathy, and elevated lactate dehydrogenase (773 U\/L). Thoracentesis confirmed chylothorax with triglyceride levels of 1.46 mmol\/L and positive Sudan III staining. On hospital day 10, the patient developed acute hyperactive delirium with visual hallucinations and paranoid behavior. Flow cytometry revealed abnormal NK-cell expansion across peripheral blood (68.09%), bone marrow (13.75%), and pleural fluid (87.34%), establishing the diagnosis of mature NK-cell lymphoma with multi-site involvement. PET-CT imaging demonstrated splenic involvement (SUVmax 9.0) and a hypodense lesion in the left occipital lobe. Despite supportive care including oxygen therapy, empirical antibiotics, and sedation, the patient rapidly progressed to hemophagocytic lymphohistiocytosis and multi-organ failure, resulting in death within four weeks of presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case demonstrates that mature NK-cell lymphoma may present with the previously unreported combination of chylothorax and acute delirium in emergency settings. Emergency physicians should maintain heightened awareness of hematologic malignancies when encountering patients with unexplained pleural effusion, neuropsychiatric symptoms, and cytopenias, as early recognition and prompt hematology consultation may influence clinical outcomes despite the typically aggressive disease course.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12245-025-01076-y","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:04:44Z","timestamp":1767031484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mature NK-cell lymphoma presenting with chylothorax and delirium: a rare emergency case"],"prefix":"10.1186","volume":"18","author":[{"given":"Wen","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"7","key":"1076_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"2","key":"1076_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/hon.2944","volume":"41","author":"X He","year":"2023","unstructured":"He X, Gao Y, Li Z, et al. Review on natural killer\/T-cell lymphoma. Hematol Oncol. 2023;41(2):221\u20139.","journal-title":"Hematol Oncol"},{"issue":"1","key":"1076_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-022-01293-5","volume":"15","author":"E Tse","year":"2022","unstructured":"Tse E, Zhao WL, Xiong J, et al. How we treat NK\/T-cell lymphomas. J Hematol Oncol. 2022;15(1):74.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"1076_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/17474086.2019.1660640","volume":"12","author":"E Tse","year":"2019","unstructured":"Tse E, Au-Yeung R, Kwong YL. Recent advances in the diagnosis and treatment of natural killer\/T-cell lymphomas. Expert Rev Hematol. 2019;12(11):927\u201335.","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"1076_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11899-016-0355-9","volume":"11","author":"BM Haverkos","year":"2016","unstructured":"Haverkos BM, Pan Z, Gru AA, et al. Extranodal NK\/T cell Lymphoma, nasal type (ENKTL-NT): an update on Epidemiology, clinical Presentation, and natural history in North American and European cases. Curr Hematol Malig Rep. 2016;11(6):514\u201327.","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"1076_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/MCP.0b013e328338dde2","volume":"16","author":"V Skouras","year":"2010","unstructured":"Skouras V, Kalomenidis I. Chylothorax: diagnostic approach. Curr Opin Pulm Med. 2010;16(4):387\u201393.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"1076_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2009.08.010","volume":"104","author":"EE McGrath","year":"2010","unstructured":"McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med. 2010;104(1):1\u20138.","journal-title":"Respir Med"},{"issue":"1","key":"1076_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13045-018-0687-0","volume":"11","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Yoon SE, Kim WS. Treatment of localized extranodal NK\/T cell lymphoma, nasal type: a systematic review. J Hematol Oncol. 2018;11(1):140.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1076_CR9","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/S2352-3026(21)00366-5","volume":"9","author":"A Setiadi","year":"2022","unstructured":"Setiadi A, Zoref-Lorenz A, Lee CY, et al. Malignancy-associated haemophagocytic lymphohistiocytosis. Lancet Haematol. 2022;9(3):e217\u201327.","journal-title":"Lancet Haematol"},{"issue":"2","key":"1076_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11739-023-03440-3","volume":"19","author":"O Miro","year":"2024","unstructured":"Miro O, Osorio G, Alquezar-Arbe A, et al. Hyperactive delirium during emergency department stay: analysis of risk factors and association with short-term outcomes. Intern Emerg Med. 2024;19(2):535\u201345.","journal-title":"Intern Emerg Med"},{"issue":"2","key":"1076_CR11","doi-asserted-by":"publisher","first-page":"210163","DOI":"10.1183\/20734735.0163-2021","volume":"18","author":"K Ur Rehman","year":"2022","unstructured":"Ur Rehman K, Sivakumar P. Non-traumatic chylothorax: diagnostic and therapeutic strategies. Breathe (Sheff). 2022;18(2):210163.","journal-title":"Breathe (Sheff)"},{"issue":"2","key":"1076_CR12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.21037\/jtd-23-1636","volume":"16","author":"M Bhatnagar","year":"2024","unstructured":"Bhatnagar M, Fisher A, Ramsaroop S, et al. Chylothorax: pathophysiology, diagnosis, and management-a comprehensive review. J Thorac Dis. 2024;16(2):1645\u201361.","journal-title":"J Thorac Dis"},{"key":"1076_CR13","doi-asserted-by":"crossref","unstructured":"Maldonado F, Hawkins FJ, Daniels CE, et al. Pleural fluid characteristics of chylothorax. Mayo Clin Proc. 2009;84(2):129\u2013133.","DOI":"10.4065\/84.2.129"},{"issue":"2","key":"1076_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/crj.12122","volume":"9","author":"AO Gomes","year":"2015","unstructured":"Gomes AO, Ribeiro S, Neves J, et al. Uncommon aetiologies of chylothorax: superior Vena Cava syndrome and thoracic aortic aneurysm. Clin Respir J. 2015;9(2):185\u20138.","journal-title":"Clin Respir J"},{"issue":"1","key":"1076_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41572-020-00223-4","volume":"6","author":"JE Wilson","year":"2020","unstructured":"Wilson JE, Mart MF, Cunningham C, et al. Delirium Nat Rev Dis Primers. 2020;6(1):90.","journal-title":"Delirium Nat Rev Dis Primers"},{"issue":"23","key":"1076_CR16","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Rosee","year":"2019","unstructured":"La Rosee P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465\u201377.","journal-title":"Blood"},{"key":"1076_CR17","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3389\/fimmu.2017.01102","volume":"8","author":"E Brisse","year":"2017","unstructured":"Brisse E, Wouters CH, Andrei G, et al. How viruses contribute to the pathogenesis of hemophagocytic lymphohistiocytosis. Front Immunol. 2017;8:1102.","journal-title":"Front Immunol"},{"issue":"22","key":"1076_CR18","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1182\/blood.2020005026","volume":"136","author":"H Kim","year":"2020","unstructured":"Kim H, Jeong H, Yamaguchi M, Sohn I, Yoon SE, Byeon S, et al. Prediction and prevention of central nervous system relapse in patients with extranodal natural killer\/T-cell lymphoma. Blood. 2020;136(22):2548\u201356.","journal-title":"Blood"},{"issue":"1","key":"1076_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","volume":"10","author":"E Tse","year":"2017","unstructured":"Tse E, Kwong Y. The diagnosis and management of NK\/T-cell lymphomas. J Hematol Oncol. 2017;10(1):85.","journal-title":"J Hematol Oncol"},{"issue":"17","key":"1076_CR20","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","volume":"129","author":"Y Kwong","year":"2017","unstructured":"Kwong Y, Chan TSY, Tan D, et al. PD1 Blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase. Blood. 2017;129(17):2437\u201342.","journal-title":"Blood"},{"issue":"9","key":"1076_CR21","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu Z, Yan Z, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet. 2015;47(9):1061\u20136.","journal-title":"Nat Genet"},{"key":"1076_CR22","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C Kucuk","year":"2015","unstructured":"Kucuk C, Jiang B, Hu X, et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat Commun. 2015;6:6025.","journal-title":"Nat Commun"},{"issue":"4","key":"1076_CR23","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1016\/S2352-3026(19)30283-2","volume":"7","author":"CP Fox","year":"2020","unstructured":"Fox CP, Civallero M, Ko Y, et al. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell project. Lancet Haematol. 2020;7(4):e284\u201394.","journal-title":"Lancet Haematol"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-01076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-025-01076-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-01076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:56:23Z","timestamp":1781625383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12245-025-01076-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1186\/s12245-025-01076-y","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report does not involve human subjects research as defined by the Institutional Review Board (IRB). Therefore, ethical approval was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the individual for publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}